utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

34 companies, 1 interpreter! Insight, foresight
and recommendation

Closing Bell

content_middle

Closing Bell

content_right

September 17, 2021 - 5:23pm | Closing Bell
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector rebounds from the quadruple witching swallowing fear

BSTG
September 16, 2021 - 4:54pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector share pricing beat-back quadruple witching

Biostage (BSTG)
September 15, 2021 - 5:09pm | Closing Bell
RegMed Investors’ (RMi) closing bell: follow the bouncing share pricings

BSTG
September 14, 2021 - 4:51pm | Closing Bell
RegMed Investors’ (RMi) closing bell: key word for today’s session - fragility

Biostage (BSTG),
September 13, 2021 - 4:50pm | Closing Bell
RegMed Investors’ (RMi) closing bell: sector action, sputtering

Biostage (BSTG),
September 10, 2021 - 5:54pm | Closing Bell
RegMed Investors’ (RMi) closing bell: losses accelerated as the session closed

Biostage (BSTG)
September 9, 2021 - 7:33pm | Closing Bell
RegMed Investors’ (RMi) closing bell: sentiment loads its soppiness
September 8, 2021 - 5:20pm | Closing Bell
RegMed Investors’ (RMi) closing bell: another cell and gene therapy session of drip, drip down on thin volume

Biostage (BSTG)
September 7, 2021 - 5:52pm | Closing Bell
RegMed Investors’ (RMi) closing bell: drip, drip down

Biostage (BSTG)
September 6, 2021 - 11:48am | Pre-Open, Closing Bell
Happy Labor Day …
September 3, 2021 - 7:10pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the cell and gene therapy highs hit the wall and bounced to the downside

Biostage (BSTG)
September 2, 2021 - 5:40pm | Closing Bell
RegMed Investors’ (RMi) closing bell: strolling to the upside on low volume
September 1, 2021 - 5:11pm | Closing Bell
RegMed Investors’ (RMi) closing bell: are we in a goldilocks continuum?

BSTG
August 31, 2021 - 5:04pm | Closing Bell
RegMed Investors’ (RMi) closing bell: August floats bye
August 30, 2021 - 5:09pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector’s upside collapsed as the session progressed
August 27, 2021 - 5:24pm | Closing Bell
RegMed Investors’ (RMi) closing bell: sector pops on rotation to biotech/healthcare
August 26, 2021 - 5:07pm | Closing Bell
RegMed Investors’ (RMi) closing bell: a challenging session fraught with sorrow
August 25, 2021 - 5:43pm | Closing Bell
RegMed Investors’ (RMi) closing bell: investors do not have an easy consensus as rebounds come and then go
August 24, 2021 - 5:36pm | Closing Bell
RegMed Investors’ (RMi) closing bell: slippin’ and trippin’ yet the cell and gene therapy sector closed with a positive Advance/Decline (A/D) line
August 23, 2021 - 5:18pm | Closing Bell
RegMed Investors’ (RMi) closing bell: are we chasing the oversold?

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.